press-releases
Lunaphore will reveal new product releases and data at the AACR Annual Meeting 2023
Date
LAUSANNE, Switzerland – March 16, 2023 – 5:00 pm (CET) – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced a series of activities at the American Association for Cancer Research (AACR) Annual Meeting 2023 taking place April 14-19 in Orlando, Florida. These include a dinner symposium, seven data presentations, and a spotlight theatre. The features of the new products will be announced prior to AACR and showcased at the conference.
The novel data and planned activities will outline COMET™’s industry-leading capabilities and highlight its wide range of research applications and broad clinical potential. Lunaphore poster presentations will showcase cutting-edge spatial biology solutions for automated analysis and demonstrate the robustness of new immuno-oncology tools with precise and reproducible results. Collaborative poster presentations will present how researchers are using COMET™ to examine tumors at a single-cell level across different tissue types and spatially analyze and characterize the tumor microenvironment (TME) in multiple cancer types.
The dinner symposium hosted by Lunaphore will feature talks and a roundtable discussion around the future of spatial biology with field experts and the Lunaphore leadership team. The company will also hold a spotlight theater highlighting the flexibility of the automated COMET™ platform to build a universal and comprehensive panel profiling the central nervous system microenvironment.
COMET™ is the only fully automated, high-throughput, hyperplex platform with superior tissue profiling capabilities. Its capacity allows the generation of high-quality and reproducible data on large cohorts of samples in days. In contrast to other spatial biology solutions, COMET™ works with off-the-shelf, label-free primary antibodies, enabling customers to use their trusted antibodies and making panel design fast and flexible.
Lunaphore poster presentations details
Validation of a novel multiplex immuno-fluorescence panel for the spatial analysis of the tumor microenvironment
Poster #: 5642, Section 43
Date and time: April 18, 1:30 pm – 5:00 pm EST
Speaker: Dr. François Rivest, Application Development Team Leader, Lunaphore
Automated multiplex immunofluorescence workflow to interrogate the cellular composition of the tumor microenvironment
Poster #: 4620, Section 4
Date and time: April 18, 1:30 pm – 5:00 pm EST
Speaker: Dr. Vytautas Navikas, Application Development Scientist, Lunaphore
Collaboration and 3rd party poster presentation details
Spatial dynamics of cytotoxic T Lymphocyte exhaustion in reactive and tumoral tissue
Poster #: 6773, Section 43
Date and time: April 19, 9:00 am – 12:30 pm EST
Speaker: Dr. Maxim De Scheppe, Resident in pathology Ph.D. laboratory for translational breast cancer, KU Leuven
Research conducted by KU Leuven, Belgium
Spatial analysis of the immunosuppressive tumor microenvironment in brain cancer applying a novel multiplex immunofluorescence panel
Poster #: 4619, Section 4
Date and time: April 18, 1:30 pm – 5:00 pm EST
Speaker: Dr. Yvonne Reiss, Group leader, Institute of Neurology (Edinger Institute), University Hospital, Goethe University, Frankfurt, Germany
Research conducted in collaboration with the Institute of Neurology (Edinger Institute), University Hospital, Goethe University, Germany
Immunotopography characterization after neoadjuvant therapy in the pancreatic cancer microenvironment
Poster #: 2254, Section 43
Date and time: April 17, 9:00 am – 12:30 pm EST
Speaker: Dr. Pamela Pulimeno, Scientific Marketing Specialist, Lunaphore
Research conducted in collaboration with the Department of Surgery, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Germany
Automated multiplex immunofluorescence enables single cell analysis of tumor stroma
Poster #: 4616, Section 4
Date and time: April 18, 1:30 pm – 5:00 pm EST
Speaker: Dr. François Rivest, Application Development Team Leader, Lunaphore
Research conducted in collaboration with Abcam, United Kingdom
Automation of proximity ligation immunoassay for PD-L1/PD-1 detection in the tumor microenvironment using microfluidic-based system
Poster #: 4336, Section 37
Date and time: April 18, 9:00 am – 12:30 pm EST
Speaker: Dr. Agata Zieba Wicher, Chief Scientific Officer, Navinci Diagnostics
Research conducted in collaboration with Navinci Diagnostics, Sweden
Spotlight Theater
Profiling the central nervous system microenvironment using hyperplex immunofluorescence
Date and time: April 17, 3:00 pm – 4:00 pm EST
Location: Theatre D, Orange County Convention Center
Speakers:
- Dr. Hinda J. Najem, Post-doctoral Fellow, Northwestern University
- Doris Loutan, Product Manager, Lunaphore
Affiliated Event | Dinner Symposium
The next decade of spatial biology
Date and time: April 17, 6:00 pm – 11:00 pm EST
Location: Rosen Center; Room: Signature 2
Speakers:
- Prof. Jérôme Galon, Head of the Laboratory of Integrative Cancer Immunology, Centre de Recherche des Cordeliers and Director of Research, French National Institute of Health and Medical Research
- Dr. Denis Schapiro, Group Leader, Heidelberg University Hospital
- Dr. Travis Hollmann, Scientific Director, Translational Medicine, Bristol Myers Squibb
- Dr. Ata Tuna Ciftlik, Founder & CEO, Lunaphore
Register here: https://lunaphore.com/our-events/aacr-2023/#form
To book a meeting or find out more about Lunaphore’s on-site activities, please visit: https://lunaphore.com/our-events/aacr-2023/
To learn more about the COMET™ platform, please visit: https://lunaphore.com/products/comet/
To learn more about Lunaphore, please visit: https://lunaphore.com/
About Lunaphore
Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily-integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit: www.lunaphore.com
About COMET™
COMET™ is a fully automated, sequential immunofluorescence (seqIF™) instrument, able to perform hyperplex staining and imaging, producing high-quality data in a robust and reproducible manner. With superior tissue profiling capabilities, the system allows multiplex analysis of 40 different spatial markers per automated run on a tissue slide. COMET™ has a wide range of research applications, allowing for a dramatic improvement in the understanding of disease pathology in areas such as immuno-oncology, neuroscience, and infectious diseases. To learn more about the COMET™ platform, please visit: https://lunaphore.com/products/comet/
For further information contact:
Irene Tamayo
Lunaphore Corporate Communications
Email: [email protected]